Postadmission serum potassium levels of 4.5-<5.0 mEq/L were associated with higher in-hospital mortality compared to levels of 3.5-<4.0 mEq/L (10.0% vs 4.8%; OR 1.99, 95% CI 1.68-2.36).
Cohort
Yes
Acute Myocardial Infarction (n=38,689)
Serum potassium levels 4.0 to <4.5 mEq/L vs Serum potassium levels 3.5 to <4.0 mEq/L
All-cause in-hospital mortality — OR 1.19 (1.04-1.36)
CONTEXT: Clinical practice guidelines recommend maintaining serum potassium levels between 4.0 and 5.0 mEq/L in patients with acute myocardial infarction (AMI). These guidelines are based on small studies that associated low potassium levels with ventricular arrhythmias in the pre-β-blocker and prereperfusion era. Current studies examining the relationship between potassium levels and mortality in AMI patients are lacking. OBJECTIVE: To determine the relationship between serum potassium levels and in-hospital mortality in AMI patients in the era of β-blocker and reperfusion therapy. DESIGN, SETTING, AND PATIENTS: Retrospective cohort study using the Cerner Health Facts database, which included 38,689 patients with biomarker-confirmed AMI, admitted to 67 US hospitals between January 1, 2000, and December 31, 2008. All patients had in-hospital serum potassium measurements and were categorized by mean postadmission serum potassium level (<3.0, 3.0-<3.5, 3.5-<4.0, 4.0-<4.5, 4.5-<5.0, 5.0-<5.5, and ≥5.5 mEq/L). Hierarchical logistic regression was used to determine the association between potassium levels and outcomes after adjusting for patient- and hospital-level factors. MAIN OUTCOME MEASURES: All-cause in-hospital mortality and the composite of ventricular fibrillation or cardiac arrest. RESULTS: There was a U-shaped relationship between mean postadmission serum potassium level and in-hospital mortality that persisted after multivariable adjustment. Compared with the reference group of 3.5 to less than 4.0 mEq/L (mortality rate, 4.8%; 95% CI, 4.4%-5.2%), mortality was comparable for mean postadmission potassium of 4.0 to less than 4.5 mEq/L (5.0%; 95% CI, 4.7%-5.3%), multivariable-adjusted odds ratio (OR), 1.19 (95% CI, 1.04-1.36). Mortality was twice as great for potassium of 4.5 to less than 5.0 mEq/L (10.0%; 95% CI, 9.1%-10.9%; multivariable-adjusted OR, 1.99; 95% CI, 1.68-2.36), and even greater for higher potassium strata. Similarly, mortality rates were higher for potassium levels of less than 3.5 mEq/L. In contrast, rates of ventricular fibrillation or cardiac arrest were higher only among patients with potassium levels of less than 3.0 mEq/L and at levels of 5.0 mEq/L or greater. CONCLUSION: Among inpatients with AMI, the lowest mortality was observed in those with postadmission serum potassium levels between 3.5 and <4.5 mEq/L compared with those who had higher or lower potassium levels.
Building similarity graph...
Analyzing shared references across papers
Loading...
Abhinav Goyal
John A. Spertus
Kensey Gosch
JAMA
Emory University
Building similarity graph...
Analyzing shared references across papers
Loading...
Goyal et al. (Tue,) conducted a cohort in Acute Myocardial Infarction (n=38,689). Serum potassium levels 4.0 to <4.5 mEq/L vs. Serum potassium levels 3.5 to <4.0 mEq/L was evaluated on All-cause in-hospital mortality (OR 1.19, 95% CI 1.04-1.36). Postadmission serum potassium levels of 4.5-<5.0 mEq/L were associated with higher in-hospital mortality compared to levels of 3.5-<4.0 mEq/L (10.0% vs 4.8%; OR 1.99, 95% CI 1.68-2.36).
www.synapsesocial.com/papers/6a0bd79cdc69176b05a940c7 — DOI: https://doi.org/10.1001/jama.2011.1967
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: